{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:58:31Z","timestamp":1774418311208,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021193","name":"Science and Technology Bureau of Xinjiang Production and Construction Corps","doi-asserted-by":"publisher","award":["2024ZD053"],"award-info":[{"award-number":["2024ZD053"]}],"id":[{"id":"10.13039\/501100021193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04075-w","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T18:34:37Z","timestamp":1760639677000},"page":"1394-1410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CHI3L1 is a diagnostic biomarker involved in immune infiltration of gastric cancer"],"prefix":"10.1007","volume":"28","author":[{"given":"Yongkang","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongtong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0492-6772","authenticated-orcid":false,"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"4075_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"4075_CR2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","volume":"385","author":"C Allemani","year":"2015","unstructured":"Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X-S, et al. Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385:977\u20131010. https:\/\/doi.org\/10.1016\/S0140-6736(14)62038-9.","journal-title":"Lancet"},{"key":"4075_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nrclinonc.2015.132","volume":"12","author":"SG Thrumurthy","year":"2015","unstructured":"Thrumurthy SG, Chaudry MA, Chau I, Allum W. Does surgery have a role in managing incurable gastric cancer? Nat Rev Clin Oncol. 2015;12:676\u201382. https:\/\/doi.org\/10.1038\/nrclinonc.2015.132.","journal-title":"Nat Rev Clin Oncol"},{"key":"4075_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1106997","volume":"13","author":"S Zhang","year":"2023","unstructured":"Zhang S, Xie Y, Yu X, Ge J, Ye G, Guo J. Absolute quantification of a plasma tRNA-derived fragment for the diagnosis and prognosis of gastric cancer. Front Oncol. 2023;13:1106997. https:\/\/doi.org\/10.3389\/fonc.2023.1106997.","journal-title":"Front Oncol"},{"key":"4075_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244869","volume":"15","author":"S-L Zhu","year":"2020","unstructured":"Zhu S-L, Dong J, Zhang C, Huang Y-B, Pan W. Application of machine learning in the diagnosis of gastric cancer based on noninvasive characteristics. PLoS ONE. 2020;15:e0244869. https:\/\/doi.org\/10.1371\/journal.pone.0244869.","journal-title":"PLoS ONE"},{"key":"4075_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-023-01131-9","volume":"56","author":"JE Yu","year":"2024","unstructured":"Yu JE, Yeo IJ, Han S-B, Yun J, Kim B, Yong YJ, et al. Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer. Exp Mol Med. 2024;56:1\u201318. https:\/\/doi.org\/10.1038\/s12276-023-01131-9.","journal-title":"Exp Mol Med"},{"key":"4075_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400524","volume":"11","author":"L Dong","year":"2024","unstructured":"Dong L, Hu S, Li X, Pei S, Jin L, Zhang L, et al. SPP1+ TAM regulates the metastatic colonization of CXCR4+ metastasis-associated tumor cells by remodeling the lymph node microenvironment. Adv Sci. 2024;11:2400524. https:\/\/doi.org\/10.1002\/advs.202400524.","journal-title":"Adv Sci"},{"key":"4075_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02731-6","volume":"9","author":"D-H Kim","year":"2018","unstructured":"Kim D-H, Park H-J, Lim S, Koo J-H, Lee H-G, Choi JO, et al. Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis. Nat Commun. 2018;9:503. https:\/\/doi.org\/10.1038\/s41467-017-02731-6.","journal-title":"Nat Commun"},{"key":"4075_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115990","volume":"24","author":"L-Y Xiao","year":"2023","unstructured":"Xiao L-Y, Su Y-L, Huang S-Y, Chen Y-H, Hsueh P-R. Chitinase 3-like-1 expression in the microenvironment is associated with neutrophil infiltration in bladder cancer. Int J Mol Sci. 2023;24:15990. https:\/\/doi.org\/10.3390\/ijms242115990.","journal-title":"Int J Mol Sci"},{"key":"4075_CR10","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1038\/onc.2017.65","volume":"36","author":"N Cohen","year":"2017","unstructured":"Cohen N, Shani O, Raz Y, Sharon Y, Hoffman D, Abramovitz L, et al. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of chitinase 3-like 1. Oncogene. 2017;36:4457\u201368. https:\/\/doi.org\/10.1038\/onc.2017.65.","journal-title":"Oncogene"},{"key":"4075_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051028","volume":"10","author":"Z Li","year":"2022","unstructured":"Li Z, Wu F, Xi L, Tian Z. Role of chitinase-3-like protein 1 in cardioprotection and angiogenesis by post-infarction exercise training. Biomedicines. 2022;10:1028. https:\/\/doi.org\/10.3390\/biomedicines10051028.","journal-title":"Biomedicines"},{"key":"4075_CR12","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.7150\/thno.82898","volume":"13","author":"JE Yu","year":"2023","unstructured":"Yu JE, Yeo IJ, Yoo SS, Kim S, Son DJ, Yun J, et al. Induction of ER stress-mediated apoptosis through SOD1 upregulation by deficiency of CHI3L1 inhibits lung metastasis. Theranostics. 2023;13:2693\u2013709. https:\/\/doi.org\/10.7150\/thno.82898.","journal-title":"Theranostics"},{"key":"4075_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00568-w","volume":"19","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Yuan Y, Yao X, Wang L, Yao L, Tang D, et al. Mipep31 alleviates sepsis development by regulating Chi3l1-dependent macrophage polarization. Biol Direct. 2024;19:117. https:\/\/doi.org\/10.1186\/s13062-024-00568-w.","journal-title":"Biol Direct"},{"key":"4075_CR14","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1113\/EP091768","volume":"109","author":"L Mi","year":"2024","unstructured":"Mi L, Jin J, Zhang Y, Chen M, Cui J, Chen R, et al. Chitinase 3-like 1 overexpression aggravates hypoxia\u2013reoxygenation injury in IEC-6 cells by inhibiting the PI3K\/AKT signalling pathway. Exp Physiol. 2024;109:2073\u201387. https:\/\/doi.org\/10.1113\/EP091768.","journal-title":"Exp Physiol"},{"key":"4075_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236569","volume":"15","author":"R Peltonen","year":"2020","unstructured":"Peltonen R, Gramkow MH, Dehlendorff C, Osterlund PJ, Johansen JS, Isoniemi H. Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases. PLoS ONE. 2020;15:e0236569. https:\/\/doi.org\/10.1371\/journal.pone.0236569.","journal-title":"PLoS ONE"},{"key":"4075_CR16","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/1878-0261.13152","volume":"16","author":"JE Yu","year":"2022","unstructured":"Yu JE, Yeo IJ, Son DJ, Yun J, Han S, Hong JT. Anti-Chi3L1 antibody suppresses lung tumor growth and metastasis through inhibition of M2 polarization. Mol Oncol. 2022;16:2214\u201334. https:\/\/doi.org\/10.1002\/1878-0261.13152.","journal-title":"Mol Oncol"},{"key":"4075_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04532-6","volume":"21","author":"S Ji","year":"2023","unstructured":"Ji S, Yu H, Zhou D, Fan X, Duan Y, Tan Y, et al. Cancer stem cell-derived CHI3L1 activates the MAF\/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer. J Transl Med. 2023;21:721. https:\/\/doi.org\/10.1186\/s12967-023-04532-6.","journal-title":"J Transl Med"},{"key":"4075_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137094","volume":"25","author":"J Zhou","year":"2024","unstructured":"Zhou J, Zhao D, Tan H, Lan J, Bao Y. CHI3L1 as a prognostic biomarker and therapeutic target in glioma. Int J Mol Sci. 2024;25:7094. https:\/\/doi.org\/10.3390\/ijms25137094.","journal-title":"Int J Mol Sci"},{"key":"4075_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/path.4761","volume":"240","author":"H Rokutan","year":"2016","unstructured":"Rokutan H, Hosoda F, Hama N, Nakamura H, Totoki Y, Furukawa E, et al. Comprehensive mutation profiling of mucinous gastric carcinoma: somatic mutations in mucinous gastric carcinoma. J Pathol. 2016;240:137\u201348. https:\/\/doi.org\/10.1002\/path.4761.","journal-title":"J Pathol"},{"key":"4075_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, Chen H-D, Yu Y-W, Li N, Chen W-Q. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J. 2021;134:783\u201391. https:\/\/doi.org\/10.1097\/CM9.0000000000001474.","journal-title":"Chin Med J"},{"issue":"7","key":"4075_CR21","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2217\/fon.09.66","volume":"5","author":"JS Johansen","year":"2009","unstructured":"Johansen JS, Schultz NA, Jensen BV. Plasma YKL-40: a potential new cancer biomarker? Future Oncol. 2009;5(7):1065\u201382. https:\/\/doi.org\/10.2217\/fon.09.66.","journal-title":"Future Oncol"},{"key":"4075_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33239-8","volume":"8","author":"Q-C Qiu","year":"2018","unstructured":"Qiu Q-C, Wang L, Jin S-S, Liu G-F, Liu J, Ma L, et al. CHI3L1 promotes tumor progression by activating TGF-\u03b2 signaling pathway in hepatocellular carcinoma. Sci Rep. 2018;8:15029. https:\/\/doi.org\/10.1038\/s41598-018-33239-8.","journal-title":"Sci Rep"},{"key":"4075_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0876-2","volume":"37","author":"B Geng","year":"2018","unstructured":"Geng B, Pan J, Zhao T, Ji J, Zhang C, Che Y, et al. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through \u03b2-catenin\/Erk\/Akt signaling in gastric cancer. J Exp Clin Cancer Res. 2018;37:208. https:\/\/doi.org\/10.1186\/s13046-018-0876-2.","journal-title":"J Exp Clin Cancer Res"},{"key":"4075_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/1533033818765209","volume":"17","author":"M Fuksiewicz","year":"2018","unstructured":"Fuksiewicz M, Kotowicz B, Rutkowski A, Achinger-Kawecka J, Wagrodzki M, Kowalska MM. The assessment of clinical usage and prognostic value of YKL-40 serum levels in patients with rectal cancer without distant metastasis. Technol Cancer Res Treat. 2018;17:1533033818765209. https:\/\/doi.org\/10.1177\/1533033818765209.","journal-title":"Technol Cancer Res Treat"},{"key":"4075_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/0963689720933241","volume":"29","author":"Y Tang","year":"2020","unstructured":"Tang Y, Qing C, Wang J, Zeng Z. DNA methylation-based diagnostic and prognostic biomarkers for glioblastoma. Cell Transplant. 2020;29:96368972093324. https:\/\/doi.org\/10.1177\/0963689720933241.","journal-title":"Cell Transplant"},{"key":"4075_CR26","doi-asserted-by":"publisher","first-page":"39740","DOI":"10.18632\/oncotarget.5469","volume":"6","author":"Y-C Chiang","year":"2015","unstructured":"Chiang Y-C, Lin H-W, Chang C-F, Chang M-C, Fu C-F, Chen T-C, et al. Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma. Oncotarget. 2015;6:39740\u201355. https:\/\/doi.org\/10.18632\/oncotarget.5469.","journal-title":"Oncotarget"},{"key":"4075_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H, Hu H. Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther. 2020;5:209. https:\/\/doi.org\/10.1038\/s41392-020-00312-6.","journal-title":"Signal Transduct Target Ther"},{"key":"4075_CR28","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1053\/j.gastro.2013.08.050","volume":"145","author":"A Katsha","year":"2013","unstructured":"Katsha A, Soutto M, Sehdev V, Peng D, Washington MK, Piazuelo MB, et al. Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia. Gastroenterology. 2013;145:1312-1322.e8. https:\/\/doi.org\/10.1053\/j.gastro.2013.08.050.","journal-title":"Gastroenterology"},{"key":"4075_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1479505","volume":"15","author":"X Zhang","year":"2025","unstructured":"Zhang X, Li B, Lan T, Chiari C, Ye X, Wang K, et al. The role of interleukin-17 in inflammation-related cancers. Front Immunol. 2025;15:1479505. https:\/\/doi.org\/10.3389\/fimmu.2024.1479505.","journal-title":"Front Immunol"},{"issue":"9","key":"4075_CR30","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.4049\/jimmunol.1000142","volume":"184","author":"X Ma","year":"2010","unstructured":"Ma X, Reynolds SL, Baker BJ, Li X, Benveniste EN, Qin H. IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J Immunol. 2010;184(9):4898\u2013906. https:\/\/doi.org\/10.4049\/jimmunol.1000142.","journal-title":"J Immunol"},{"key":"4075_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12935-024-03425-y","volume":"24","author":"Y Fan","year":"2024","unstructured":"Fan Y, Meng Y, Xingwei Hu, Liu J, Qin X. Uncovering novel mechanisms of chitinase-3-like protein 1 in driving inflammation-associated cancers. Cancer Cell Int. 2024;24:268. https:\/\/doi.org\/10.1186\/s12935-024-03425-y. (PMID: 39068486).","journal-title":"Cancer Cell Int"},{"key":"4075_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ph17030307","volume":"17","author":"M-C Chang","year":"2024","unstructured":"Chang M-C, Chen C-T, Chiang P-F, Chiang Y-C. The role of chitinase-3-like protein-1 (YKL40) in the therapy of cancer and other chronic-inflammation-related diseases. Pharmaceuticals. 2024;17:307. https:\/\/doi.org\/10.3390\/ph17030307.","journal-title":"Pharmaceuticals"},{"key":"4075_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1146840","volume":"14","author":"C Ma","year":"2023","unstructured":"Ma C, Li F, Gu Z, Yang Y, Qi Y. A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma. Front Pharmacol. 2023;14:1146840. https:\/\/doi.org\/10.3389\/fphar.2023.1146840.","journal-title":"Front Pharmacol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04075-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04075-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04075-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:05:00Z","timestamp":1774415100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04075-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["4075"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04075-w","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that there are no poten- tial conflicts of interest associated with this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We confirm that this study involving human participants was conducted in accordance with the ethical standards of the Institutional  Review Board (IRB) of the First Affiliated Hospital of Shihezi University School of Medicine (Shihezi, Xinjiang, China) and the 1964 Helsinki Declaration and its later amendments. The study protocol received ethical approval from the same committee (Approval No: KJ2025-298-01). Informed consent was obtained from all individual participants included in the study. The ethical approval document has been provided in the supplementary files.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Informed consent"}}]}}